Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC

Arkadiusz Z. Dudek, Priya Kumar, Sunn Sunn H. Thaw, Qing Cao, Pamala Pawloski, Timothy Larson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences